Share Facebook Twitter LinkedIn Pinterest Email Enliven Therapeutics GAAP EPS of -$0.48 beats by $0.02
ZTO forecasts 2026 parcel volume growth of 6% to 10% as it targets RMB 0.03 core transit cost declines (NYSE:ZTO)August 19, 2026
